ATLAS / Macro Radar / Reporting / TVTX

Travere Therapeutics, Inc. (TVTX) reporting calendar

Travere Therapeutics, Inc. files periodic reports with the SEC as TVTX on Nasdaq. Atlas tracks 45 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
22 Jul 2026 – 13 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
4 May 2026
Reports on record
45

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 33 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open TVTX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20264 May 202634 days0001438533-26-000042
10-K31 Dec 202519 Feb 202650 days0001438533-26-000014
10-Q30 Sep 202530 Oct 202530 days0001438533-25-000056
10-Q30 Jun 20256 Aug 202537 days0001438533-25-000046
10-Q31 Mar 20251 May 202531 days0001438533-25-000026
10-K31 Dec 202421 Feb 202552 days0001438533-25-000010
10-Q30 Sep 202431 Oct 202431 days0001438533-24-000048
10-Q30 Jun 20241 Aug 202432 days0001438533-24-000031
10-Q31 Mar 20246 May 202436 days0001438533-24-000020
10-K31 Dec 202320 Feb 202451 days0001438533-24-000005
10-Q30 Sep 20237 Nov 202338 days0001438533-23-000048
10-Q30 Jun 20233 Aug 202334 days0001438533-23-000039
10-Q31 Mar 20234 May 202334 days0001438533-23-000024
10-K31 Dec 202223 Feb 202354 days0001438533-23-000008
10-Q30 Sep 202227 Oct 202227 days0001438533-22-000051
10-Q30 Jun 20224 Aug 202235 days0001438533-22-000032
10-Q31 Mar 20225 May 202235 days0001438533-22-000025
10-K31 Dec 202124 Feb 202255 days0001438533-22-000008
10-Q30 Sep 202129 Oct 202129 days0001438533-21-000053
10-Q30 Jun 202129 Jul 202129 days0001438533-21-000034
10-Q31 Mar 20216 May 202136 days0001438533-21-000016
10-K31 Dec 20201 Mar 202160 days0001438533-21-000008
10-Q30 Sep 20205 Nov 202036 days0001438533-20-000031
10-Q30 Jun 202031 Jul 202031 days0001438533-20-000022
10-Q31 Mar 202011 May 202041 days0001438533-20-000011
10-K31 Dec 201924 Feb 202055 days0001438533-20-000004
10-Q30 Sep 201930 Oct 201930 days0001438533-19-000036
10-Q30 Jun 20196 Aug 201937 days0001438533-19-000024
10-Q31 Mar 20197 May 201937 days0001438533-19-000011
10-K31 Dec 201826 Feb 201957 days0001438533-19-000003
10-Q30 Sep 20181 Nov 201832 days0001438533-18-000032
10-Q30 Jun 20183 Aug 201834 days0001438533-18-000028
10-Q31 Mar 20181 May 201831 days0001438533-18-000016
10-K31 Dec 201727 Feb 201858 days0001438533-18-000006
10-Q30 Sep 20177 Nov 201738 days0001438533-17-000034
10-Q30 Jun 20179 Aug 201740 days0001438533-17-000029
10-Q31 Mar 20175 May 201735 days0001438533-17-000017
10-K31 Dec 20161 Mar 201760 days0001438533-17-000005
10-Q30 Sep 20164 Nov 201635 days0001628280-16-020847
10-Q30 Jun 20165 Aug 201636 days0001628280-16-018545

Source: SEC EDGAR company submissions for CIK 0001438533. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.